Cover Image
Market Research Report
Product code 
1109741

Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2022 - 2030

Published: | Next Move Strategy Consulting | 462 Pages | Delivery time: 1-2 business days

Price

Back to Top
Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2022 - 2030
Published: August 1, 2022
Next Move Strategy Consulting
Content info: 462 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Market Definition:

At an estimated value of over USD 10.08 billion in 2021, the Global Acne Medication Market is predicted to thrive at a CAGR of 3.4% and valued at over USD 14.26 billion over the forecast year 2022-2030 Acne is the most common skin conditions typically caused by changes in structures of the skin. It affects almost millions of adolescents around the globe. Hence, there is huge demand for topical as well as oral acne medication. Topical medication includes creams, gels, and ointments that consist of retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medication is relatively more effective where moderate to severe acne do not respond to topical agents.

Market Dynamics and Trends

Numerous factors such as changing hormone levels, rising teenage population, and growing adoption of skincare products significantly drive the growth of global acne medication market. In addition, excessive production of oil from sebaceous glands and unhygienic lifestyle causes the occurrence of acne, thus impacting positively on the market growth. However, side-effects such as skin irritation, dry skin, and erythema or skin redness due to the utilization of acne medications is expected to hamper growth of the market. On the contrary, increased R&D in skin care along with the high market potential across untapped emerging countries is expected to be opportunistic for the market growth. Further, growing occurrence and severity of acne is one of the major factors that will fuel the market size during forecast period

Market Segmentations and Scope of the Study:

The global acne medication market share is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and geography. On the basis of therapeutic class, the market is categorized into retinoids, antibiotics, benzoyl peroxide, salicylic acid, and others. According to the formulation, the market is segmented into topical medications and oral medications. As per the type, the market is divided into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne. As per the distribution channel, it is categorized as retail stores, e-commerce, and pharmacies & drug stores. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis

In terms of geography, North America held major share of the market in 2020. This is attributed to the surge in use of skin care products and increased awareness about natural acne medication has propelled the demand for acne medication across this region. However, Asia-pacific is expected to grow rapidly with increasing market size due to the factors such as up surge in healthcare expenditure and higher demand for acne therapeutics across developing countries in the region.

Competitive Landscape

Maximum growth opportunities make the Acne Medication market highly competitive. Some of the major players in the market are Almirall SA., Bausch Health Companies Inc., Galderma S.A, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan N.V., Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd. and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in June 2020, Bausch Health Companies Inc. and Ortho Dermatologics, announced that ARAZLO (tazarotene) Lotion is available commercially to health care professionals across the U.S. ARAZLO is the tazarotene acne treatment medicine which is available in lotion formulation.

Also, in February 2020, Almirall, S.A. (ALM) announced the development of Seysara (sarecycline), the advanced tetracycline-derived oral antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. The product is expected to be submitted to National Medical Products Administration (NMPA) in 2023.

KEY MARKET SEGMENTS:

  • Global Acne Medication Market- By Therapeutic Class
  • Retinoids
  • Topical & combination retinoids
  • Oral retinoid (Isotretinoin)
  • Antibiotics
  • Topical & combination antibiotics
  • Oral antibiotics
  • Benzoyl Peroxide
  • Salicylic Acid
  • Others
  • Global Acne Medication Market - By Formulation
  • Topical Medications
  • Oral Medications
  • Global Acne Medication Market - By Type
  • Prescription Medicines
  • Over-The-Counter Medicines
  • Global Acne Medication Market - By Acne Type
  • Non-Inflammatory Acne
  • Inflammatory Acne
  • Global Acne Medication Market - By Distribution Channel
  • Retail Stores
  • E-Commerce
  • Pharmacies & Drug Stores
  • Global Acne Medication Market - By Geography
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • RoW
  • Brazil
  • Saudi Arabia
  • South Africa
  • Remaining Countries

TABLE OF CONTENTS

1.INTRODUCTION

1.1.REPORT DESCRIPTION

1.2.WHO SHOULD READ THIS REPORT

1.3.KEY MARKET SEGMENTS

1.4.RESEARCH METHODOLOGY

1.4.1SECONDARY RESEARCH

1.4.2DATA ANALYSIS FRAMEWORK

1.4.3MARKET SIZE ESTIMATION

1.4.4FORECASTING

1.4.5PRIMARY RESEARCH AND DATA VALIDATION

2.ACNE MEDICATION MARKET - EXECUTIVE SUMMARY

2.1.MARKET SNAPSHOT, 2022 - 2030, MILLION USD

3.MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE

3.2.MARKET DYNAMICS

3.2.1DRIVERS

3.2.1.1Unhealthy food habits and rise in sedentary lifestyles

3.2.1.2Occurrence of acne vulgaris condition in teenagers & adults

3.2.1.3Rising awareness about the overall appearance, health, and attire

3.2.2RESTRAINTS

3.2.2.1Side-effects related with the usage of acne medications and substitute acne treatment options

3.2.3OPPORTUNITIES

3.2.3.1Emergence & development of effective acne medications with minor side effects

3.2.3.2Significant market potential in untapped developing countries

4.COVID-19 ANALYSIS

4.1.IMPACT ON MARKET SIZE

4.2.END USER TRENDS & PREFERENCES, AND BUDGET & ECONOMIC IMPACT

4.3.KEY PLAYER STRATEGIES TO TACKLE COVID-19'S INFLUENCE ON MARKET

5.MARKET SHARE ANALYSIS

5.1.MARKET SHARE ANALYSIS OF TOP ACNE MEDICATION PROVIDERS, 2021

6.GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

6.1.OVERVIEW

6.2.RETINOIDS

6.2.1GLOBAL RETINOIDS MARKET, BY THERAPEUTIC CLASS

6.2.1.1Topical Retinoid & Combination RETIONOID MARKET, By Region

        • 6.2.1.1.1North America Topical Retinoid & Combination Retionoid Market, By Country
        • 6.2.1.1.2Europe Topical Retinoid & Combination Retionoid Market, By Country
        • 6.2.1.1.3Asia-Pacific Topical Retinoid & Combination Retionoid Market, By Country
        • 6.2.1.1.4Rest of World Topical Retinoid & Combination Retionoid Market, By Country

6.2.1.2Oral Retinoid (Isoretinion) Market, By Region

        • 6.2.1.2.1North America Oral Retinoid (Isoretinion) Market, By Country
        • 6.2.1.2.2Europe Oral Retinoid (Isoretinion) Market, By Country
        • 6.2.1.2.3Asia-Pacific Oral Retinoid (Isoretinion) Market, By Country
        • 6.2.1.2.4Rest of World Oral Retinoid (Isoretinion) Market, By Country

6.2.2RETINOIDS MARKET, BY REGION

6.2.2.1North America Retinoids Market, By Country

6.2.2.2Europe Retinoids Market, By Country

6.2.2.3Asia-Pacific Retinoids Market, By Country

6.2.2.4Rest of World Retinoids Market, By Country

6.3.ANTIBIOTICS

6.3.1GLOBAL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

6.3.1.1Topical Antibiotic & Combination Antibiotics Market, By Region

        • 6.3.1.1.1North America Topical Antibiotic & Combination Antibiotics Market, By Country
        • 6.3.1.1.2Europe Topical Antibiotic & Combination Antibiotics Market, By Country
        • 6.3.1.1.3Asia-Pacific Topical Antibiotic & Combination Antibiotics Market, By Country
        • 6.3.1.1.4Rest of World Topical Antibiotic & Combination Antibiotics Market, By Country

6.3.1.2Oral Antibiotic Market, By Region

        • 6.3.1.2.1North America Oral Antibiotic Market, By Country
        • 6.3.1.2.2Europe Oral Antibiotic Market, By Country
        • 6.3.1.2.3Asia-Pacific Oral Antibiotic Market, By Country
        • 6.3.1.2.4Rest of World Oral Antibiotic Market, By Country

6.3.2ANTIBIOTICS MARKET, BY REGION

6.3.2.1North America Antibiotics Market, By Country

6.3.2.2Europe Antibiotics Market, By Country

6.3.2.3Asia-Pacific Antibiotics Market, By Country

6.3.2.4Rest of World Antibiotics Market, By Country

6.4.SALICYLIC ACID

6.4.1SALICYLIC ACID MARKET, BY REGION

6.4.1.1North America Salicylic Acid Market, By Country

6.4.1.2Europe Salicylic Acid Market, By Country

6.4.1.3Asia-Pacific Salicylic Acid Market, By Country

6.4.1.4Rest of World Salicylic Acid Market, By Country

6.5.BENZOYL PEROXIDE

6.5.1BENZOYL PEROXIDE MARKET, BY REGION

6.5.1.1North America Benzoyl Peroxide Market, By Country

6.5.1.2Europe Benzoyl Peroxide Market, By Country

6.5.1.3Asia-Pacific Benzoyl Peroxide Market, By Country

6.5.1.4Rest of World Benzoyl Peroxide Market, By Country

6.6.OTHERS

6.6.1GLOBAL OTHERS MARKET, BY THERAPEUTIC CLASS

6.6.1.1Other Topicals (Azelaic acid) Market, By Region

        • 6.6.1.1.1North America Other Topicals (Azelaic acid) Market, By Country
        • 6.6.1.1.2Europe Other Topicals (Azelaic acid) Market, By Country
        • 6.6.1.1.3Asia-Pacific Other Topicals (Azelaic acid) Market, By Country
        • 6.6.1.1.4Rest of World Other Topicals (Azelaic acid) Market, By Country

6.6.1.2Others OTC Market, By Region

        • 6.6.1.2.1North America Others OTC Market, By Country
        • 6.6.1.2.2Europe Others OTC Market, By Country
        • 6.6.1.2.3Asia-Pacific Others OTC Market, By Country
        • 6.6.1.2.4Rest of World Others OTC Market, By Country

6.6.2OTHERS MARKET, BY REGION

6.6.2.1North America Others Market, By Country

6.6.2.2Europe Others Market, By Country

6.6.2.3Asia-Pacific Others Market, By Country

6.6.2.4Rest of World Others Market, By Country

7.GLOBAL ACNE MEDICATION MARKET, BY FORMULATION

7.1.OVERVIEW

7.2.TOPICAL MEDICATIONS

7.2.1TOPICAL MEDICATIONS MARKET, BY REGION

7.2.1.1North America Topical Medications Market, By Country

7.2.1.2Europe Topical Medications Market, By Country

7.2.1.3Asia-Pacific Topical Medications Market, By Country

7.2.1.4Rest of World Topical Medications Market, By Country

7.3.ORAL MEDICATIONS

7.3.1ORAL MEDICATIONS MARKET, BY REGION

7.3.1.1North America Oral Medications Market, By Country

7.3.1.2Europe Oral Medications Market, By Country

7.3.1.3Asia-Pacific Oral Medications Market, By Country

7.3.1.4Rest of World Oral Medications Market, By Country

8.GLOBAL ACNE MEDICATION MARKET, BY TYPE

8.1.OVERVIEW

8.2.PRESCRIPTION MEDICINES

8.2.1PRESCRIPTION MEDICINES MARKET, BY REGION

8.2.1.1North America Prescription Medicines Market, By Country

8.2.1.2Europe Prescription Medicines Market, By Country

8.2.1.3Asia-Pacific Prescription Medicines Market, By Country

8.2.1.4Rest of World Prescription Medicines Market, By Country

8.3.OVER-THE-COUNTER (OTC) MEDICINES

8.3.1OVER-THE-COUNTER (OTC )MEDICINES MARKET, BY REGION

8.3.1.1North America Over-the-counter (OTC )Medicines Market, By Country

8.3.1.2Europe Over-the-counter (OTC )Medicines Market, By Country

8.3.1.3Asia-Pacific Over-the-counter (OTC )Medicines Market, By Country

8.3.1.4Rest of World Over-the-counter (OTC )Medicines Market, By Country

9.GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE

9.1.OVERVIEW

9.2.INFLAMMATORY ACNE

9.2.1INFLAMMATORY ACNE MARKET, BY REGION

9.2.1.1North America Inflammatory Acne Market, By Country

9.2.1.2Europe Inflammatory Acne Market, By Country

9.2.1.3Asia-Pacific Inflammatory Acne Market, By Country

9.2.1.4Rest of World Inflammatory Acne Market, By Country

9.3.NON-INFLAMMATORY ACNE

9.3.1NON-INFLAMMATORY ACNE MARKET, BY REGION

9.3.1.1North America Non-inflammatory Acne Market, By Country

9.3.1.2Europe Non-inflammatory Acne Market, By Country

9.3.1.3Asia-Pacific Non-inflammatory Acne Market, By Country

9.3.1.4Rest of World Non-inflammatory Acne Market, By Country

10.GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

10.1.OVERVIEW

10.2.GROCERY SHOPS

10.2.1GROCERY SHOPS MARKET, BY REGION

10.2.1.1North America Grocery Shops Market, By Country

10.2.1.2Europe Grocery Shops Market, By Country

10.2.1.3Asia-Pacific Grocery Shops Market, By Country

10.2.1.4Rest of World Grocery Shops Market, By Country

10.3.PHARMACIES & DRUG STORES

10.3.1PHARMACIES & DRUG STORES MARKET, BY REGION

10.3.1.1North America Pharmacies & Drug Stores Market, By Country

10.3.1.2Europe Pharmacies & Drug Stores Market, By Country

10.3.1.3Asia-Pacific Pharmacies & Drug Stores Market, By Country

10.3.1.4Rest of World Pharmacies & Drug Stores Market, By Country

10.4.E-COMMERCE

10.4.1E-COMMERCE MARKET, BY REGION

10.4.1.1North America e-Commerce Market, By Country

10.4.1.2Europe e-Commerce Market, By Country

10.4.1.3Asia-Pacific e-Commerce Market, By Country

10.4.1.4Rest of World e-Commerce Market, By Country

11.GLOBAL ACNE MEDICATION MARKET, BY REGION

11.1.OVERVIEW

11.2.NORTH AMERICA

11.2.1NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.2.1.1North America Retinoids Market, By Therapeutic Class

11.2.1.2North America Antibiotics Market, By Therapeutic Class

11.2.1.3North America Others Market, By Therapeutic Class

11.2.2NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION

11.2.3NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE

11.2.4NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE

11.2.5NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11.2.6NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY

11.2.6.1U.S.

        • 11.2.6.1.1U.S. Acne Medication Market, By Therapeutic Class
        • 11.2.6.1.1.1.U.S. Retinoids Market, By Therapeutic Class
        • 11.2.6.1.1.2.U.S. Antibiotics Market, By Therapeutic Class
        • 11.2.6.1.1.3.U.S. Others Market, By Therapeutic Class
        • 11.2.6.1.2U.S. Acne Medication Market, By Formulation
        • 11.2.6.1.3U.S. Acne Medication Market, By Type
        • 11.2.6.1.4U.S. Acne Medication Market, By Acne Type
        • 11.2.6.1.5U.S. Acne Medication Market, By Distribution Channel

11.2.6.2Canada

        • 11.2.6.2.1Canada Acne Medication Market, By Therapeutic Class
        • 11.2.6.2.1.1.Canada Retinoids Market, By Therapeutic Class
        • 11.2.6.2.1.2.Canada Antibiotics Market, By Therapeutic Class
        • 11.2.6.2.1.3.Canada Others Market, By Therapeutic Class
        • 11.2.6.2.2Canada Acne Medication Market, By Formulation
        • 11.2.6.2.3Canada Acne Medication Market, By Type
        • 11.2.6.2.4Canada Acne Medication Market, By Acne Type
        • 11.2.6.2.5Canada Acne Medication Market, By Distribution Channel

11.2.6.3Mexico

        • 11.2.6.3.1Mexico Acne Medication Market, By Therapeutic Class
        • 11.2.6.3.1.1.Mexico Retinoids Market, By Therapeutic Class
        • 11.2.6.3.1.2.Mexico Antibiotics Market, By Therapeutic Class
        • 11.2.6.3.1.3.Mexico Others Market, By Therapeutic Class
        • 11.2.6.3.2Mexico Acne Medication Market, By Formulation
        • 11.2.6.3.3Mexico Acne Medication Market, By Type
        • 11.2.6.3.4Mexico Acne Medication Market, By Acne Type
        • 11.2.6.3.5Mexico Acne Medication Market, By Distribution Channel

11.3.EUROPE

11.3.1EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.1.1Europe Retinoids Market, By Therapeutic Class

11.3.1.2Europe Antibiotics Market, By Therapeutic Class

11.3.1.3Europe Others Market, By Therapeutic Class

11.3.2EUROPE ACNE MEDICATION MARKET, BY FORMULATION

11.3.3EUROPE ACNE MEDICATION MARKET, BY TYPE

11.3.4EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11.3.6EUROPE ACNE MEDICATION MARKET, BY COUNTRY

11.3.6.1Germany

        • 11.3.6.1.1Germany Acne Medication Market, By Therapeutic Class
        • 11.3.6.1.1.1.Germany Retinoids Market, By Therapeutic Class
        • 11.3.6.1.1.2.Germany Antibiotics Market, By Therapeutic Class
        • 11.3.6.1.1.3.Germany Others Market, By Therapeutic Class
        • 11.3.6.1.2Germany Acne Medication Market, By Formulation
        • 11.3.6.1.3Germany Acne Medication Market, By Type
        • 11.3.6.1.4Germany Acne Medication Market, By Acne Type
        • 11.3.6.1.5Germany Acne Medication Market, By Distribution Channel

11.3.6.2France

        • 11.3.6.2.1France Acne Medication Market, By Therapeutic Class
        • 11.3.6.2.1.1.France Retinoids Market, By Therapeutic Class
        • 11.3.6.2.1.2.France Antibiotics Market, By Therapeutic Class
        • 11.3.6.2.1.3.France Others Market, By Therapeutic Class
        • 11.3.6.2.2France Acne Medication Market, By Formulation
        • 11.3.6.2.3France Acne Medication Market, By Type
        • 11.3.6.2.4France Acne Medication Market, By Acne Type
        • 11.3.6.2.5France Acne Medication Market, By Distribution Channel

11.3.6.3UK

        • 11.3.6.3.1UK Acne Medication Market, By Therapeutic Class
        • 11.3.6.3.1.1.UK Retinoids Market, By Therapeutic Class
        • 11.3.6.3.1.2.UK Antibiotics Market, By Therapeutic Class
        • 11.3.6.3.1.3.UK Others Market, By Therapeutic Class
        • 11.3.6.3.2UK Acne Medication Market, By Formulation
        • 11.3.6.3.3UK Acne Medication Market, By Type
        • 11.3.6.3.4UK Acne Medication Market, By Acne Type
        • 11.3.6.3.5UK Acne Medication Market, By Distribution Channel

11.3.6.4Italy

        • 11.3.6.4.1Italy Acne Medication Market, By Therapeutic Class
        • 11.3.6.4.1.1.Italy Retinoids Market, By Therapeutic Class
        • 11.3.6.4.1.2.Italy Antibiotics Market, By Therapeutic Class
        • 11.3.6.4.1.3.Italy Others Market, By Therapeutic Class
        • 11.3.6.4.2Italy Acne Medication Market, By Formulation
        • 11.3.6.4.3Italy Acne Medication Market, By Type
        • 11.3.6.4.4Italy Acne Medication Market, By Acne Type
        • 11.3.6.4.5Italy Acne Medication Market, By Distribution Channel

11.3.6.5Spain

        • 11.3.6.5.1Spain Acne Medication Market, By Therapeutic Class
        • 11.3.6.5.1.1.Spain Retinoids Market, By Therapeutic Class
        • 11.3.6.5.1.2.Spain Antibiotics Market, By Therapeutic Class
        • 11.3.6.5.1.3.Spain Others Market, By Therapeutic Class
        • 11.3.6.5.2Spain Acne Medication Market, By Formulation
        • 11.3.6.5.3Spain Acne Medication Market, By Type
        • 11.3.6.5.4Spain Acne Medication Market, By Acne Type
        • 11.3.6.5.5Spain Acne Medication Market, By Distribution Channel

11.3.6.6Rest of Europe

        • 11.3.6.6.1Rest of Europe Acne Medication Market, By Therapeutic Class
        • 11.3.6.6.1.1.Rest of Europe Retinoids Market, By Therapeutic Class
        • 11.3.6.6.1.2.Rest of Europe Antibiotics Market, By Therapeutic Class
        • 11.3.6.6.1.3.Rest of Europe Others Market, By Therapeutic Class
        • 11.3.6.6.2Rest of Europe Acne Medication Market, By Formulation
        • 11.3.6.6.3Rest of Europe Acne Medication Market, By Type
        • 11.3.6.6.4Rest of Europe Acne Medication Market, By Acne Type
        • 11.3.6.6.5Rest of Europe Acne Medication Market, By Distribution Channel

11.4.ASIA-PACIFIC

11.4.1ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.1.1Asia-Pacific Retinoids Market, By Therapeutic Class

11.4.1.2Asia-Pacific Antibiotics Market, By Therapeutic Class

11.4.1.3Asia-Pacific Others Market, By Therapeutic Class

11.4.2ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION

11.4.3ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE

11.4.4ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11.4.6ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY

11.4.6.1Japan

        • 11.4.6.1.1Japan Acne Medication Market, By Therapeutic Class
        • 11.4.6.1.1.1.Japan Retinoids Market, By Therapeutic Class
        • 11.4.6.1.1.2.Japan Antibiotics Market, By Therapeutic Class
        • 11.4.6.1.1.3.Japan Others Market, By Therapeutic Class
        • 11.4.6.1.2Japan Acne Medication Market, By Formulation
        • 11.4.6.1.3Japan Acne Medication Market, By Type
        • 11.4.6.1.4Japan Acne Medication Market, By Acne Type
        • 11.4.6.1.5Japan Acne Medication Market, By Distribution Channel

11.4.6.2China

        • 11.4.6.2.1China Acne Medication Market, By Therapeutic Class
        • 11.4.6.2.1.1.China Retinoids Market, By Therapeutic Class
        • 11.4.6.2.1.2.China Antibiotics Market, By Therapeutic Class
        • 11.4.6.2.1.3.China Others Market, By Therapeutic Class
        • 11.4.6.2.2China Acne Medication Market, By Formulation
        • 11.4.6.2.3China Acne Medication Market, By Type
        • 11.4.6.2.4China Acne Medication Market, By Acne Type
        • 11.4.6.2.5China Acne Medication Market, By Distribution Channel

11.4.6.3India

        • 11.4.6.3.1India Acne Medication Market, By Therapeutic Class
        • 11.4.6.3.1.1.India Retinoids Market, By Therapeutic Class
        • 11.4.6.3.1.2.India Antibiotics Market, By Therapeutic Class
        • 11.4.6.3.1.3.India Others Market, By Therapeutic Class
        • 11.4.6.3.2India Acne Medication Market, By Formulation
        • 11.4.6.3.3India Acne Medication Market, By Type
        • 11.4.6.3.4India Acne Medication Market, By Acne Type
        • 11.4.6.3.5India Acne Medication Market, By Distribution Channel

11.4.6.4Australia

        • 11.4.6.4.1Australia Acne Medication Market, By Therapeutic Class
        • 11.4.6.4.1.1.Australia Retinoids Market, By Therapeutic Class
        • 11.4.6.4.1.2.Australia Antibiotics Market, By Therapeutic Class
        • 11.4.6.4.1.3.Australia Others Market, By Therapeutic Class
        • 11.4.6.4.2Australia Acne Medication Market, By Formulation
        • 11.4.6.4.3Australia Acne Medication Market, By Type
        • 11.4.6.4.4Australia Acne Medication Market, By Acne Type
        • 11.4.6.4.5Australia Acne Medication Market, By Distribution Channel

11.4.6.5South Korea

        • 11.4.6.5.1South Korea Acne Medication Market, By Therapeutic Class
        • 11.4.6.5.1.1.South Korea Retinoids Market, By Therapeutic Class
        • 11.4.6.5.1.2.South Korea Antibiotics Market, By Therapeutic Class
        • 11.4.6.5.1.3.South Korea Others Market, By Therapeutic Class
        • 11.4.6.5.2South Korea Acne Medication Market, By Formulation
        • 11.4.6.5.3South Korea Acne Medication Market, By Type
        • 11.4.6.5.4South Korea Acne Medication Market, By Acne Type
        • 11.4.6.5.5South Korea Acne Medication Market, By Distribution Channel

11.4.6.6Rest of Asia-Pacific

        • 11.4.6.6.1Rest of Asia-Pacific Acne Medication Market, By Therapeutic Class
        • 11.4.6.6.1.1.Rest of Asia-Pacific Retinoids Market, By Therapeutic Class
        • 11.4.6.6.1.2.Rest of Asia-Pacific Antibiotics Market, By Therapeutic Class
        • 11.4.6.6.1.3.Rest of Asia-Pacific Others Market, By Therapeutic Class
        • 11.4.6.6.2Rest of Asia-Pacific Acne Medication Market, By Formulation
        • 11.4.6.6.3Rest of Asia-Pacific Acne Medication Market, By Type
        • 11.4.6.6.4Rest of Asia-Pacific Acne Medication Market, By Acne Type
        • 11.4.6.6.5Rest of Asia-Pacific Acne Medication Market, By Distribution Channel

11.5.REST OF WORLD

11.5.1REST OF WORLD ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.5.1.1Rest of World Retinoids Market, By Therapeutic Class

11.5.1.2Rest of World Antibiotics Market, By Therapeutic Class

11.5.1.3Rest of World Others Market, By Therapeutic Class

11.5.2REST OF WORLD ACNE MEDICATION MARKET, BY FORMULATION

11.5.3REST OF WORLD ACNE MEDICATION MARKET, BY TYPE

11.5.4REST OF WORLD ACNE MEDICATION MARKET, BY ACNE TYPE

11.5.5REST OF WORLD ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11.5.6REST OF WORLD ACNE MEDICATION MARKET, BY COUNTRY

11.5.6.1Brazil

        • 11.5.6.1.1Brazil Acne Medication Market, By Therapeutic Class
        • 11.5.6.1.1.1.Brazil Retinoids Market, By Therapeutic Class
        • 11.5.6.1.1.2.Brazil Antibiotics Market, By Therapeutic Class
        • 11.5.6.1.1.3.Brazil Others Market, By Therapeutic Class
        • 11.5.6.1.2Brazil Acne Medication Market, By Formulation
        • 11.5.6.1.3Brazil Acne Medication Market, By Type
        • 11.5.6.1.4Brazil Acne Medication Market, By Acne Type
        • 11.5.6.1.5Brazil Acne Medication Market, By Distribution Channel

11.5.6.2Saudi Arabia

        • 11.5.6.2.1Saudi Arabia Acne Medication Market, By Therapeutic Class
        • 11.5.6.2.1.1.Saudi Arabia Retinoids Market, By Therapeutic Class
        • 11.5.6.2.1.2.Saudi Arabia Antibiotics Market, By Therapeutic Class
        • 11.5.6.2.1.3.Saudi Arabia Others Market, By Therapeutic Class
        • 11.5.6.2.2Saudi Arabia Acne Medication Market, By Formulation
        • 11.5.6.2.3Saudi Arabia Acne Medication Market, By Type
        • 11.5.6.2.4Saudi Arabia Acne Medication Market, By Acne Type
        • 11.5.6.2.5Saudi Arabia Acne Medication Market, By Distribution Channel

11.5.6.3South Africa

        • 11.5.6.3.1South Africa Acne Medication Market, By Therapeutic Class
        • 11.5.6.3.1.1.South Africa Retinoids Market, By Therapeutic Class
        • 11.5.6.3.1.2.South Africa Antibiotics Market, By Therapeutic Class
        • 11.5.6.3.1.3.South Africa Others Market, By Therapeutic Class
        • 11.5.6.3.2South Africa Acne Medication Market, By Formulation
        • 11.5.6.3.3South Africa Acne Medication Market, By Type
        • 11.5.6.3.4South Africa Acne Medication Market, By Acne Type
        • 11.5.6.3.5South Africa Acne Medication Market, By Distribution Channel

11.5.6.4Remaining Countries

        • 11.5.6.4.1Remaining Countries Acne Medication Market, By Therapeutic Class
        • 11.5.6.4.1.1.Remaining Countries Retinoids Market, By Therapeutic Class
        • 11.5.6.4.1.2.Remaining Countries Antibiotics Market, By Therapeutic Class
        • 11.5.6.4.1.3.Remaining Countries Others Market, By Therapeutic Class
        • 11.5.6.4.2Remaining Countries Acne Medication Market, By Formulation
        • 11.5.6.4.3Remaining Countries Acne Medication Market, By Type
        • 11.5.6.4.4Remaining Countries Acne Medication Market, By Acne Type
        • 11.5.6.4.5Remaining Countries Acne Medication Market, By Distribution Channel

12.COMPANY PROFILES

12.1.ALMIRALL S.A.

12.1.1COMPANY OVERVIEW

12.1.2COMPANY SNAPSHOT

12.1.3PRODUCT PORTFOLIO

12.1.4BUSINESS PERFORMANCE

12.1.5KEY STRATEGIC MOVES & DEVELOPMENTS

12.1.6PRIMARY MARKET COMPETITORS

12.2.BAUSCH HEALTH COMPANIES INC.

12.2.1COMPANY OVERVIEW

12.2.2COMPANY SNAPSHOT

12.2.3OPERATING BUSINESS SEGMENTS

12.2.4PRODUCT PORTFOLIO

12.2.5BUSINESS PERFORMANCE

12.2.6SALES BY BUSINESS SEGMENT

12.2.7SALES BY GEOGRAPHIC SEGMENT

12.2.8KEY STRATEGIC MOVES & DEVELOPMENTS

12.2.9PRIMARY MARKET COMPETITORS

12.3.JOHNSON & JOHNSON

12.3.1COMPANY OVERVIEW

12.3.2COMPANY SNAPSHOT

12.3.3OPERATING BUSINESS SEGMENTS

12.3.4PRODUCT PORTFOLIO

12.3.5BUSINESS PERFORMANCE

12.3.6SALES BY BUSINESS SEGMENT

12.3.7SALES BY GEOGRAPHIC SEGMENT

12.3.8KEY STRATEGIC MOVES & DEVELOPMENTS

12.3.9PRIMARY MARKET COMPETITORS

12.4.GLAXOSMITHKLINE PLC

12.4.1COMPANY OVERVIEW

12.4.2COMPANY SNAPSHOT

12.4.3OPERATING BUSINESS SEGMENTS

12.4.4PRODUCT PORTFOLIO

12.4.5BUSINESS PERFORMANCE

12.4.6SALES BY BUSINESS SEGMENT

12.4.7SALES BY GEOGRAPHIC SEGMENT

12.4.8KEY STRATEGIC MOVES & DEVELOPMENTS

12.4.9PRIMARY MARKET COMPETITORS

12.5.GALDERMA

12.5.1COMPANY OVERVIEW

12.5.2COMPANY SNAPSHOT

12.5.3PRODUCT PORTFOLIO

12.5.4KEY STRATEGIC MOVES & DEVELOPMENTS

12.5.5PRIMARY MARKET COMPETITORS

12.6.MAYNE PHARMA GROUP LIMITED

12.6.1COMPANY OVERVIEW

12.6.2COMPANY SNAPSHOT

12.6.3OPERATING BUSINESS SEGMENTS

12.6.4PRODUCT PORTFOLIO

12.6.5BUSINESS PERFORMANCE

12.6.6SALES BY BUSINESS SEGMENT

12.6.7SALES BY GEOGRAPHIC SEGMENT

12.6.8KEY STRATEGIC MOVES & DEVELOPMENTS

12.6.9PRIMARY MARKET COMPETITORS

12.7.VIATRIS INC.

12.7.1COMPANY OVERVIEW

12.7.2COMPANY SNAPSHOT

12.7.3OPERATING BUSINESS SEGMENTS

12.7.4PRODUCT PORTFOLIO

12.7.5BUSINESS PERFORMANCE

12.7.6OPERATING BUSINESS SEGMENTS

12.7.7SALES BY BUSINESS SEGMENT

12.7.8SALES BY GEOGRAPHIC SEGMENT

12.7.9KEY STRATEGIC MOVES & DEVELOPMENTS

12.7.10PRIMARY MARKET COMPETITORS

12.8.SUN PHARMACEUTICAL INDUSTRIES LIMITED

12.8.1COMPANY OVERVIEW

12.8.2COMPANY SNAPSHOT

12.8.3PRODUCT PORTFOLIO

12.8.4BUSINESS PERFORMANCE

12.8.5SALES BY BUSINESS SEGMENT

12.8.6SALES BY GEOGRAPHIC SEGMENT

12.8.7KEY STRATEGIC MOVES & DEVELOPMENTS

12.8.8PRIMARY MARKET COMPETITORS

12.9.PFIZER INC.

12.9.1COMPANY OVERVIEW

12.9.2COMPANY SNAPSHOT

12.9.3OPERATING BUSINESS SEGMENTS

12.9.4PRODUCT PORTFOLIO

12.9.5BUSINESS PERFORMANCE

12.9.6SALES BY BUSINESS SEGMENT

12.9.7SALES BY GEOGRAPHIC SEGMENT

12.9.8KEY STRATEGIC MOVES & DEVELOPMENTS

12.9.9PRIMARY MARKET COMPETITORS

12.10.TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.10.1COMPANY OVERVIEW

12.10.2COMPANY SNAPSHOT

12.10.3PRODUCT PORTFOLIO

12.10.4BUSINESS PERFORMANCE

12.10.5SALES BY BUSINESS SEGMENT

12.10.6SALES BY GEOGRAPHIC SEGMENT

12.10.7KEY STRATEGIC MOVES & DEVELOPMENTS

12.10.8PRIMARY MARKET COMPETITORS